Literature DB >> 30038384

MDM2 controls gene expression independently of p53 in both normal and cancer cells.

Giuseppe Arena1, Romain Riscal2,3, Laetitia K Linares4,5, Laurent Le Cam6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30038384      PMCID： PMC6143619          DOI： 10.1038/s41418-018-0156-x

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  15 in total

1.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; J B Clark; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

2.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

3.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

4.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

5.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

6.  MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.

Authors:  Magdalena Wienken; Antje Dickmanns; Alice Nemajerova; Daniela Kramer; Zeynab Najafova; Miriam Weiss; Oleksandra Karpiuk; Moustapha Kassem; Yanping Zhang; Guillermina Lozano; Steven A Johnsen; Ute M Moll; Xin Zhang; Matthias Dobbelstein
Journal:  Mol Cell       Date:  2015-12-31       Impact factor: 17.970

7.  Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53.

Authors:  Giuseppe Arena; Madi Yann Cissé; Samuel Pyrdziak; Laurent Chatre; Romain Riscal; Maryse Fuentes; Jamie Jon Arnold; Markus Kastner; Laurie Gayte; Christelle Bertrand-Gaday; Kevin Nay; Claire Angebault-Prouteau; Kerren Murray; Beatrice Chabi; Christelle Koechlin-Ramonatxo; Béatrice Orsetti; Charles Vincent; François Casas; Jean-Christophe Marine; Sandrine Etienne-Manneville; Florence Bernex; Anne Lombès; Craig Eugene Cameron; Hervé Dubouchaud; Miria Ricchetti; Laetitia Karine Linares; Laurent Le Cam
Journal:  Mol Cell       Date:  2018-02-15       Impact factor: 17.970

8.  MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.

Authors:  M C Dubs-Poterszman; B Tocque; B Wasylyk
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

Review 9.  p53-independent effects of Mdm2.

Authors:  Stephen Bohlman; James J Manfredi
Journal:  Subcell Biochem       Date:  2014

Review 10.  Mdm2 as a chromatin modifier.

Authors:  Magdalena Wienken; Ute M Moll; Matthias Dobbelstein
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216
View more
  9 in total

Review 1.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

Review 2.  Anastasis: cell recovery mechanisms and potential role in cancer.

Authors:  Rebar N Mohammed; Mohsen Khosravi; Heshu Sulaiman Rahman; Ali Adili; Navid Kamali; Pavel Petrovich Soloshenkov; Lakshmi Thangavelu; Hossein Saeedi; Navid Shomali; Rozita Tamjidifar; Alireza Isazadeh; Ramin Aslaminabad; Morteza Akbari
Journal:  Cell Commun Signal       Date:  2022-06-03       Impact factor: 7.525

3.  Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.

Authors:  Ines Oršolić; Slađana Bursać; Deana Jurada; Irena Drmić Hofman; Zlatko Dembić; Jiri Bartek; Ivana Mihalek; Siniša Volarević
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

4.  Chemopreventive Agent 3,3'-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells.

Authors:  Xiang Gao; Jingwen Liu; Kwang Bog Cho; Samanthreddy Kedika; Bin Guo
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

5.  Smyd2 conformational changes in response to p53 binding: role of the C-terminal domain.

Authors:  Balasubramanian Chandramouli; Gerry Melino; Giovanni Chillemi
Journal:  Mol Oncol       Date:  2019-05-21       Impact factor: 6.603

Review 6.  Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Authors:  Lucia Haronikova; Ondrej Bonczek; Pavlina Zatloukalova; Filip Kokas-Zavadil; Martina Kucerikova; Philip J Coates; Robin Fahraeus; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2021-12-15       Impact factor: 5.787

Review 7.  Do Mutations Turn p53 into an Oncogene?

Authors:  Consuelo Pitolli; Ying Wang; Mara Mancini; Yufang Shi; Gerry Melino; Ivano Amelio
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

Review 8.  Commensal microbes and p53 in cancer progression.

Authors:  Ivana Celardo; Gerry Melino; Ivano Amelio
Journal:  Biol Direct       Date:  2020-11-19       Impact factor: 4.540

9.  Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.

Authors:  Tania Velletri; Yin Huang; Yu Wang; Qing Li; Mingyuan Hu; Ningxia Xie; Qian Yang; Xiaodong Chen; Qing Chen; Peishun Shou; Yurun Gan; Eleonora Candi; Margherita Annicchiarico-Petruzzelli; Massimiliano Agostini; Huilin Yang; Gerry Melino; Yufang Shi; Ying Wang
Journal:  Cell Death Differ       Date:  2020-07-21       Impact factor: 15.828
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.